CoChat

Advances in the preclinical testing of cancer therapeutic hypotheses

Caponigro, Giordano, Sellers, William R. · 2011 · Nature Reviews Drug Discovery

The DOI matches its Crossref record; 88 of the 89 references it cites were found in a registry or an index.

Abstract

The genetic and epigenetic underpinnings of cancer are becoming increasingly clear owing to impressive and well-coordinated ventures occurring worldwide. As our understanding of the molecular alterations driving human cancer increases, there is an opportunity to direct the clinical application of cancer therapeutics with improved accuracy. The often empirical treatment of cancer--which was initially based on inhibiting DNA synthesis and cellular division--while having led to a number of remarkable successes, remains prone to a high rate of clinical failure that results partly from a lack of understanding of how best to implement drugs in the clinic. Consequently, it is vital that robust translational strategies be developed preclinically to both reduce failure rates in the clinic and shorten the time required to identify patient populations most likely to benefit from a given therapeutic. Here, we review both historical and current uses of preclinical model systems, being mindful that a combination of approaches will be needed to address all meritorious therapeutic hypotheses.

Overview

Integrity signals

Registry

Crossref · 10.1038/nrd3385

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 88 references

Research works printed but not linked: 2

  1. Fantini, A., Moser, L., Partridge, R. & Halliday, J. L. The effect of actinomycin D on several mouse tumors. Proc. Am. Assoc. Cancer Res. 2, 108 (1956).
  2. Farber, S. Carcinolytic action of antibiotics: puromycin and actinomycin D. Am. J. Pathol. 31, 582 (1955).

Cited by

Metadata

Authors
Caponigro, G., & Sellers, W. R.
Corresponding author
Caponigro, Giordano
Venue
Nature Reviews Drug Discovery
Published
2011-03
Volume
10
Issue
3
Pages
179-187
ISSN
  • 1474-1776 (ISSN-L)
  • 1474-1784
OpenAlex
W2091336659
Cited by
165
References
89
Citations by year
2026: 3 · 2025: 13 · 2024: 8 · 2023: 11 · 2022: 14 · 2021: 18 · 2020: 10 · 2019: 15 · 2018: 7 · 2017: 4 · 2016: 16 · 2015: 6 · 2014: 10 · 2013: 12 · 2012: 14
FWCI
1.18
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Nature Reviews Drug Discovery (publishedVersion)
  • PubMed (publishedVersion)
Funders
Novartis Institutes for BioMedical Research
Topics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
Keywords
preclinical cancer models, translational oncology, anticancer drug development, drug attrition, clinical trial failure, patient selection
MeSH terms
Animals, Antineoplastic Agents, Disease Models, Animal, Drug Evaluation, Preclinical, Genetic Engineering, Humans, Models, Biological, Neoplasms, Cell Line, Tumor, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.